Active	Status	Sponsor type	Region	Phase	Filter
3 Active 12 Inactive 15 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
AlloStim (bioengineered allogeneic immune cells) / Immunovative
ALIVE, NCT05033522: Immunotherapy for Advanced Liver Cancer	Recruiting	2/3	150	RoW	AlloStim® immunotherapy, FOLFOX regimen, Physician Choice FOLFOX4, Sorafenib, Sorafenib Physician's Choice, Lenvatinib, Levantinib Physician's Choice	Immunovative Therapies, Ltd., Mirror Biologics, Inc.	Hepatocellular Carcinoma	08/25	12/25
STIMVAX, NCT04444622: Immunotherapy for Third Line Metastatic Colorectal Cancer	Recruiting	2	24	US	AlloStim, StimVax	Immunovative Therapies, Ltd., Mirror Biologics, Inc.	Metastatic Colorectal Cancer	11/24	04/25
ALLOPRIME, NCT04441047: Universal Anti-Viral Vaccine for Healthy Elderly Adults	Completed	1/2	40	US	AlloStim	Immunovative Therapies, Ltd., Mirror Biologics, Inc.	Virus Diseases, Pneumonia, COVID-19 Respiratory Infection, RSV Pneumonia, Influenza, Human, ARDS, Human	03/23	04/23
AlloVax (CRCL/AlloStim) / Immunovative
No trials found